This list is an analysis based on recent market events. It's not an investment recommendation.
About
CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies. It also develops CRG-023, a tri-specific CAR T product candidate that targets tumor cells with three B-cell antigen targets. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is headquartered in San Mateo, California.
Show more...
CEO
Mr. Anup Radhakrishnan
Employees
167
Country
United States
ISIN
US14179K1016
Listings
0 Comments
Share your thoughts
FAQ
What is CARGO Therapeutics stock price today?▼
The current price of CRGX is $4.47 USD — it has decreased by -1.54% in the past 24 hours. Watch CARGO Therapeutics stock price performance more closely on the chart.
What is CARGO Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange CARGO Therapeutics stocks are traded under the ticker CRGX.
What is CARGO Therapeutics revenue for the last year?▼
CARGO Therapeutics revenue for the last year amounts to 0 USD.
What is CARGO Therapeutics net income for the last year?▼
CRGX net income for the last year is -167.5M USD.
How many employees does CARGO Therapeutics have?▼
As of September 08, 2026, the company has 167 employees.
In which sector is CARGO Therapeutics located?▼
CARGO Therapeutics operates in the Health & Wellness sector.
When did CARGO Therapeutics complete a stock split?▼
CARGO Therapeutics has not had any recent stock splits.
Where is CARGO Therapeutics headquartered?▼
CARGO Therapeutics is headquartered in San Carlos, United States.